XRTX XORTX Therapeutics Inc.

Nasdaq xortx.com


$ 0.55 $ -0.02 (-3.1 %)    

Thursday, 20-Nov-2025 12:00:59 EST
QQQ $ 593.34 $ -18.32 (-3 %)
DIA $ 460.18 $ -6.58 (-1.41 %)
SPY $ 658.81 $ -14.09 (-2.09 %)
TLT $ 89.32 $ 0.33 (0.37 %)
GLD $ 372.53 $ -2.65 (-0.71 %)
$ 0.5454
$ 0.56
$ 0.54 x 100
$ 0.56 x 200
$ 0.54 - $ 0.56
$ 0.52 - $ 1.79
42,447
na
2.07M
$ 4.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 xortx-therapeutics-issues-73871-shares-at-154-in-q1-2025-raising-net-proceeds-of-1097k-under-atm-program

Issuance of Shares under ATM OfferingIn other news, the Company confirms the issuance of 73,871 common shares at US$1.54 (CAD $...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION